Slideshow

IMaSS Scientific network for innovation IMaSS aims Sponsorship

1st IMaSS Pharma Network 2015

1st IMaSS Pharma Network 2015

Mass Spectrometry from Drug Discovery to Lifecycle management

26th- 28th October 2015
Aptuit Auditorium

Center for Drug Discovery & Development
Via Fleming 4, Verona, Italy



Monday, October 26th, 15:30-16:30 Opening Lecture:

Andrea Chiesi (Chiesi Farmaceutici S.p.a.)

"Holoclar®, the first stem cell-based medicinal product"




The aim of the 1st IMaSS Network is the creation of a network among scientists working in pharmaceutical and biopharmaceutical fields, both academic and industrial.
Nowadays, the role of mass spectrometry along the life drug is well established and its support spread in all the R&D phases. For this reason, the congress will be organized to update the participants on the latest technological improvements of mass spectrometry as well as on its application from pharmaceutical Discovery to manufacturing and Lifecycle management.

Topics as antibody characterization, quality control of biopharmaceuticals, formulation, ADME, HDX will be presented. Particular emphasis will be addressed to the emerging biopharmaceutical world.

Invited Speakers

Andrea Chiesi (Chiesi Farmaceutici - Italy)
Davy Guillame (University of Geneve and Lausanne - Switzerland)
David Lascoux (Waters Corporation - EHQ France)
Edith Monteaguto (IRBM - Italiy)
Koen Sandra (Metablys & RIC - Belgium)
Cinzia Stella (Genentech, USA)
Alain Van Doersselaer (IPHC - France)
Mario Varasi (IEO, Italy)


See the congress Book of Abstract:



Organizing Committee

Fabio Bonelli, IRBM, Roma
Ornella Curcuruto, Aptuit - Center for Drug Discovery & Development, Verona
Valentina Mileo, Chiesi Farmaceutici, Parma
Angelo Palmese, MerckGroup, Roma
Simona Scarpella, Nerviano Medical Sciences, Milano
Caterina Temporini, University of Pavia, Pavia